(Total Views: 609)
Posted On: 08/13/2024 9:05:18 PM
Post# of 154090
I've seen a few posts, here and elsewhere, mentioning the possibility of approval after the CRC Phase 2, with a post-approval Phase 3.
Obviously we'd all love to see that.
My question is, would that possibility (or not), or the odds of it, have been discussed in Cytodyn's recent FDA meeting? Curious if mgmt might touch on the subject in any future CC. Would love to know it's even remotely possible or whether we should all wind our necks in and assume P3 will be a must. Knowing what dicks the FDA have been, I'm going to keep said neck wound in.
Obviously we'd all love to see that.
My question is, would that possibility (or not), or the odds of it, have been discussed in Cytodyn's recent FDA meeting? Curious if mgmt might touch on the subject in any future CC. Would love to know it's even remotely possible or whether we should all wind our necks in and assume P3 will be a must. Knowing what dicks the FDA have been, I'm going to keep said neck wound in.
(7)
(0)
